Outer membrane vesicles from X‐ray‐irradiated Pseudomonas aeruginosa alleviate lung injury caused by P.aeruginosa infection‐mediated sepsis

• Published in: APMIS : acta pathologica, microbiologica et immunologica Scandinavica Vol. 132; no. 9; pp. 646 - 656
• Main Authors: Bi, Hongxia, Qin, Jiayuan, Huang, Jiaqi, Zhong, Cejun, Liu, Yanbin
• Format: Journal Article
• Language: English
• Published: Copenhagen Wiley Subscription Services, Inc 01.09.2024
• Subjects: Alveoli; Bacteria; Colonies; Edema; Hemorrhage; Infections; Inflammation; Injury prevention; Leukocytes (neutrophilic); Lungs; Macrophages; Medical treatment; Membrane vesicles; Membranes; Pseudomonas aeruginosa; Sepsis; Vaccine development; Vesicles
• ISSN: 0903-4641; 1600-0463
• DOI: 10.1111/apm.13444

Pseudomonas aeruginosa infection causes pneumonia and sepsis. Previous research found that X‐ray radiation can induce P. aeruginosa to release outer membrane vesicles (OMVs) of relatively consistent sizes. This study found that OMVs derived from X‐ray‐irradiated P. aeruginosa can significantly inhibit lung leakage, inflammatory cell infiltrating into lung, and the production of pro‐inflammatory cytokines, IL‐1β and TNFα caused by P. aeruginosa infection under preventive and therapeutic administration conditions. Under the same conditions, OMVs also significantly alleviated pathological characteristics of lung injury, including pulmonary edema, pulmonary hemorrhage, and alveolar wall thickening. OMVs also significantly reduced bacterial burdens in peritoneal cavity, accompanied by a reduction in the number of viable bacteria capable of forming bacterial colonies. Pretreating macrophages and neutrophils with OMVs enhances their bactericidal ability. When bacteria were cocultured with treated cells, the number of viable bacteria capable of forming bacterial colonies was significantly reduced. OMVs themselves have not been shown to cause any lung injury or affect bacterial viability. Therefore, OMVs derived from X‐ray‐irradiated P. aeruginosa may not only be applied in prevention and treatment of diseases associated with P. aeruginosa infection, but also served as an excellent vaccine development platform.